Form 13-F position report

FULGENT GENETICS INC COM

Reported by MORGAN STANLEY

FLGT CUSIP 359664109 Manager CIK 0000895421

Reported 197,601 shares, up 38,132 (23.9%) from the prior quarter.

Reported value 33.0%; share count 23.9% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 197,601 Quarter-end amount reported
Reported value $4,351,173 Fair value at quarter end
Consecutive quarters held 41 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 17756000
2022-03-31 13343000
2022-06-30 13199000
2022-09-30 11027000
2022-12-31 7864540
2023-03-31 9456757
2023-06-30 8169151
2023-09-30 6694574
2023-12-31 7611626
2024-03-31 4779384
2024-06-30 7242397
2024-09-30 10155139
2024-12-31 10010244
2025-03-31 3044344
2025-06-30 4454605
2025-09-30 6250214
2025-12-31 8281715
2026-03-31 3059219
2026-06-30 3272318
2026-09-30 4351173

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for FULGENT GENETICS INC COM held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 197,601 +38,132 (23.9%) < 0.01% $4,351,173 2026-11-13
Q2 2026 Reduced 159,469 -32,934 (-17.1%) < 0.01% $3,272,318 2026-08-13
Q1 2026 Reduced 192,403 -122,850 (-39.0%) < 0.01% $3,059,219 2026-05-15
Q4 2025 Added 315,253 +38,695 (14.0%) < 0.01% $8,281,715 2026-02-13
Q3 2025 Added 276,558 +52,484 (23.4%) < 0.01% $6,250,214 2025-11-14
Q2 2025 Added 224,074 +43,936 (24.4%) < 0.01% $4,454,605 2025-08-15
Q1 2025 Reduced 180,138 -361,834 (-66.8%) < 0.01% $3,044,344 2025-05-15
Q4 2024 Added 541,972 +74,640 (16.0%) < 0.01% $10,010,244 2025-02-14
Q3 2024 Added 467,332 +98,199 (26.6%) < 0.01% $10,155,139 2024-11-14
Q2 2024 Added 369,133 +148,885 (67.6%) < 0.01% $7,242,397 2024-08-14
Q1 2024 Reduced 220,248 -43,038 (-16.3%) < 0.01% $4,779,384 2024-05-15
Q4 2023 Added 263,286 +12,929 (5.2%) < 0.01% $7,611,626 2024-02-13
Q3 2023 Added 250,357 +29,749 (13.5%) < 0.01% $6,694,574 2023-11-15
Q2 2023 Reduced 220,608 -82,299 (-27.2%) < 0.01% $8,169,151 2023-08-14
Q1 2023 Added 302,907 +38,819 (14.7%) < 0.01% $9,456,757 2023-05-15
Q4 2022 Reduced 264,088 -25,199 (-8.7%) < 0.01% $7,864,540 2023-02-14
Q3 2022 Added 289,287 +47,227 (19.5%) < 0.01% $11,027,000 2022-11-14
Q2 2022 Added 242,060 +28,270 (13.2%) < 0.01% $13,199,000 2022-08-15
Q1 2022 Added 213,790 +37,266 (21.1%) < 0.01% $13,343,000 2022-05-13
Q4 2021 Added 176,524 +12,889 (7.9%) < 0.01% $17,756,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

157 managers reported FULGENT GENETICS INC COM for Q3 2026.

Managers reporting FULGENT GENETICS INC COM in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 2,439,788 +153,119 < 0.01% $53,724,131 9 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 1,090,951 +73,038 0.03% $24,008,000 11 qtrs
Diametric Capital LP Added 932,410 +234,626 1.72% $20,531,668 8 qtrs
TWO SIGMA INVESTMENTS LP Added 929,450 +528,464 0.01% $20,466,489 11 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 765,873 -23,625 < 0.01% $16,864,523 3 qtrs
AMERIPRISE FINANCIAL INC Reduced 666,636 -3,448 < 0.01% $14,679,324 27 qtrs
DIMENSIONAL FUND ADVISORS LP Added 646,625 +21,270 < 0.01% $14,238,857 35 qtrs
JACOBS LEVY EQUITY MANAGEMENT INC Reduced 583,499 -198,617 0.05% $12,848,648 3 qtrs
JPMorgan Chase & Co Reduced 516,112 -240,446 < 0.01% $11,395,753 29 qtrs
STATE STREET CORPORATION Added 516,943 +18,270 < 0.01% $11,383,085 26 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
194,432
Shared
0
None
3,169

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.